From: The role of prognostic nutritional index in the management of pulmonary sarcomatoid carcinoma
Variables | Cases (n) | PNI (mean ± SD) | P-value |
---|---|---|---|
Sex | 0.084 | ||
Male | 69 | 48.83 ± 5.89 | |
Female | 22 | 51.19 ± 4.07 | |
Age (years) | 0.170 | ||
≤ 60 | 51 | 50.11 ± 5.66 | |
> 60 | 40 | 48.49 ± 5.39 | |
Smoking history | 0.692 | ||
Former/current smoker | 51 | 49.19 ± 5.98 | |
Never-smoker | 40 | 49.66 ± 5.07 | |
Alcohol abuse | 0.615 | ||
Yes | 37 | 49.04 ± 6.05 | |
No | 54 | 49.65 ± 5.26 | |
Histologic subtype | 0.919 | ||
Giant/spindle cell carcinoma | 87 | 49.41 ± 5.60 | |
Other subtype | 4 | 49.12 ± 5.81 | |
Tumor size (cm) | 0.120 | ||
≤ 5 | 38 | 50.48 ± 5.82 | |
> 5 | 53 | 48.63 ± 5.31 | |
Tumor stage | 0.008 | ||
T1–2 | 31 | 51.53 ± 5.23 | |
T3–4 | 60 | 48.30 ± 5.46 | |
Tumor location | 0.670 | ||
Peripheral | 37 | 48.76 ± 6.04 | |
Central | 9 | 49.78 ± 4.42 | |
Both | 45 | 49.85 ± 5.43 | |
Nodal metastasis | 0.048 | ||
N0 | 54 | 50.35 ± 5.68 | |
N1–3 | 37 | 48.01 ± 5.17 | |
Pathological stage(8th edition) | 0.001 | ||
Ia–IIa | 34 | 51.96 ± 5.31 | |
IIb–IIIc | 57 | 47.88 ± 5.19 | |
Treatment modality | 0.959 | ||
Surgery | 31 | 47.97 ± 5.28 | |
Surgery + adjuvant CT | 30 | 51.27 ± 5.46 | |
Surgery + adjuvant CT + targeted therapy | 30 | 49.00 ± 5.63 |